Leader of Series B-2 Financing Round Matthew Katz Joins AIVITA’s Board of Directors IRVINE, Calif., Feb. 25, 2020 /PRNewswire/ — AIVITA Biomedical, Inc., a biotechnology company (the “Company”) specializing in innovative stem cell applications, announced today the first closing of its $25 million Series B-2 preferred stock investment round. The first closing of $12.5 million was … Continued

IRVINE, Calif., Aug. 14, 2019 /PRNewswire/ — AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced today updated clinical data from its ongoing glioblastoma Phase 2 clinical trial, investigating AIVITA’s platform immunotherapy targeting tumor-initiating cells. Blood plasma biomarker analyses have identified a robust immune response and a decrease of tumor biomarkers in … Continued

AlivaMab Mouse Emerging as Top Pharmas’ Next-Generation Antibody Drug Discovery Platform of Choice BURLINGAME, Calif.–(BUSINESS WIRE)– 2, 2016 – Ablexis, LLC announced today the expansion of the roster of licensees of its AlivaMab Mouse technology to include an additional top 15 pharmaceutical company. The AlivaMab Mouse is a unique, next-generation transgenic mouse platform for human … Continued

MariaDB has been selected as Database of the Year in the Members’ Choice awards at LinuxQuestions.org for the third year running. The LinuxQuestions.org forum is the largest Linux user forum online, hosting from 100,000 to a million visitors every month. In a resounding show of support, fans gave MariaDB 45.5% of the vote, more than … Continued

FDA Expands Label Indication for PleuraFlow to Reduce Retained Blood | Business Wire ANAHEIM, Calif.–(BUSINESS WIRE)–ClearFlow, Inc., a medical device company based in Anaheim, California, announced today that the United States Food & Drug Administration (FDA) has granted expanded Indications for Use of the company’s patented PleuraFlow® Active Clearance Technology® System. The PleuraFlow System is … Continued